Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Conclusions: Antihypertensive therapy in pregnancy with Labetalol may have the potential to impair fetal behavior in low degrees hypertensivediseasesofpregnancy.
1
However, long-term data are lacking among women with gestationalhypertension without proteinuria.
2
Maternal adverse pregnancy outcomes were pre-eclampsia, gestational diabetes, and gestationalhypertension.
3
We ascertained gestationalhypertension, pre-eclampsia, gestational diabetes and preterm birth diagnoses from medical records.
4
Patients: A total of 65 women with gestationalhypertension at 24-26 weeks.
5
When looking at gestationalhypertension and pre-eclampsia as outcomes, (multiple) logistic regression was used in the analysis.
1
The results were adjusted for maternal age, gestational age and pregnancy-inducedhypertension.
2
During her last pregnancy, Michelle was diagnosed with pre-eclampsia, or pregnancy-inducedhypertension.
3
Group 1 patients had a significantly higher incidence of pregnancy-inducedhypertension and preterm birth.
4
Of all the interaction terms, only the bromocriptine by pregnancy-inducedhypertension interaction was significant.
5
Incidence of pregnancy-inducedhypertension or preeclampsia, gestational week at delivery and birthweight were recorded.
Translations for hypertension complicating pregnancy